Search IPOs
BMLL · NSE · healthcare and pharma
Bio Medica Laboratories IPO listed on 29 May 2026 on NSE at ₹111.20, a loss of 19.28% over the issue price of ₹139.00. The IPO was subscribed 2.31x overall.
Bio Medica Laboratories IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 21 May 2026 |
| IPO Close Date | 25 May 2026 |
| Basis of Allotment | 26 May 2026 |
| Initiation of Refunds | 27 May 2026 |
| Credit of Shares to Demat | 27 May 2026 |
| Listing Date | 29 May 2026 |
Listing day gain
-19.28%
Listed at ₹111.2 (issue ₹139)
Issue
₹139
Listing
₹111.2
Current
₹115.8
-16.69% vs issue
Day range
₹105.65 – ₹116.75
Issue Size
3,772,000 shares
(aggregating up to ₹52.00 Cr)
Issue Price
₹132 – ₹139
Face Value
₹10/share
Market Lot
1,000 shares
Retail Min Investment
₹278,000
Listing At
NSE
Sale Type
both
Fresh Issue
3,206,000 shares
(aggregating up to ₹45 Cr)
Offer for Sale
377,000 shares
(aggregating up to ₹5 Cr)
Reserved for Market Maker
189,000 shares
(aggregating up to ₹3.00 Cr)
Issue Type
book building
Open Date
21 May
Close Date
25 May
Allotment
26 May
Listing
29 May
Last updated: 4 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 28 May 2026 Latest | ₹139 | ₹-6 | ₹133 | ₹-6 |
-4.32%
|
10:36 AM |
| 27 May 2026 | ₹139 | ₹-6 | ₹133 | ₹-6 |
-4.32%
|
11:13 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 25 May 2026
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 15.94x | 6 |
| NII | 1.41x | 457 |
| bNII (bids above ₹10L) | 1.02x | 35 |
| sNII (bids below ₹10L) | 2.19x | 422 |
| Individual Investors | 2.92x | 2,614 |
| Total | 2.31x | 3,534 |
Showing the latest subscription snapshot.
View full subscription historyMr. Mukesh Mehta and Mr. Pradeep Mehta are the promoters of the Company.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹278,000 |
| Retail (Max) | 2 | 2,000 | ₹278,000 |
| S-HNI (Min) | 3 | 3,000 | ₹417,000 |
| S-HNI (Max) | 7 | 7,000 | ₹973,000 |
| B-HNI (Min) | 8 | 8,000 | ₹1,112,000 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 36,000 (0.95%) |
| NII (HNI) Shares Offered | 1,755,000 (46.53%) |
|
•
bNII > ₹10L
|
1,170,000 (31.02%) |
|
•
sNII < ₹10L
|
585,000 (15.51%) |
| Individual Investors Shares Offered | 1,792,000 (47.51%) |
| Market Maker Shares Offered | 189,000 (5.01%) |
| Total Shares Offered | 3,772,000 (100.00%) |
Bio Medica Laboratories has been around since 2015, and it does one thing — makes injectable medicines. We're talking liquid injections and dry powder injections, sold for both human use and veterinary purposes. The product range isn't small either: 58 liquid injectable products and 15 dry powder types, covering everything from antibiotics like Ceftriaxone and Amikacin, to Vitamin B12 shots, anti-malarials, and even pain drugs like Buprenorphine.
The company operates out of Madhya Pradesh and holds a GMP certificate from the state's Food & Drugs Administration — which basically means its facility meets standard manufacturing norms. It sells across over ten states including Gujarat, Karnataka, Tamil Nadu, and Uttar Pradesh.
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Total Revenue | 16.25 | 15.34 | 38.33 |
| Profit After Tax (PAT) | 0.33 | 2.5 | 9.79 |
| EBITDA | 1.7 | 5.63 | 15.21 |
| Total Assets | 17.57 | 19.53 | 39.12 |
| Net Worth | 2.44 | 4.94 | 14.73 |
| Reserves & Surplus | 2.34 | 4.84 | 5.55 |
| Total Borrowing | 9.61 | 10.49 | 15.01 |
Revenue & Profit Trend
The basis of allotment for Bio Medica Laboratories IPO was finalised on 26 May 2026. You can check your allotment status using your PAN number or application number on the Skyline Financial Services Pvt.Ltd. portal or BSE.
The Bio Medica Laboratories IPO is expected to open in May 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Bio Medica Laboratories IPO is ₹132.00 - ₹139.00 per share.
As per market sources, Bio Medica Laboratories IPO GMP is currently ₹-6.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Bio Medica Laboratories IPO stands at 2.31x overall.
The listing date for Bio Medica Laboratories IPO is 29 May 2026.
No comments yet. Be the first to comment!
